When I was at the Business School in 2016, I wrote a composition about blockchain and its implications in medical care. At that time, all experts proclaimed with confidence that this new technology would “revolutionize” medical care. I remember thinking about that moment that I really did not understand. The systemic problems that exist in medical care, with misaligned economic incentives that drive the behavior of the system that rewards the disease instead of well -being, would be approached remotely by blockchain technology. Absolutely, Blockchain helps guarantee the privacy of data, but that is a specific solution, not a comprehensive…
Author: Rachel Collins
Cohere Health closed a financing round of series C $ 90 million on Wednesday, taking its total financing to date to $ 200 million. The Boston company, founded in 2019, aims to fix inefficiencies and administrative burden associated with the traditional prioritization process. When rationalizing this process, Chere, seeks to reduce treatment delays and reduce the workload of medical care providers, said CEO Siva Namasivayam. The startup automates prior authorization by digitizing authorization requests and evaluating them against medical guidelines using AI, he explained. This system is integrated with the EHR of a supplier, which allows faster suppliers, as well…
Data and system integration is less glamorous compared to the latest conversations on how AI can improve the provision of medical care and results. However, for AI or other technologies to succeed, a solid and well integrated data exchange environment is required. This base is essential to share medical data between internal or external hospital systems, or between telemedicine suppliers and hospital systems. It also directly affects staff productivity and is key to carry out data sciences to evaluate the results and develop strategies for new or expanded telemedicine services. Without Integration Working at Best Performance Level, Health Care Systems…
Until now, 2025 has been everything less soft for UnitedHealth Group. The health giant announced Tuesday that Andrew Witty will resign as CEO due to “personal reasons.” It is replaced by Stephen J. Hemsley, who served as CEO of the company from 2006 to 2017. Hemsley Willin as president of the UHG Board of Directors, and Witty will be Hemsley. “Leading the people of United Group has been a great honor while working every day to improve the health system, and continue to inspire me,” Witty said in a statement. The company also announced that it has suspended its 2025…
Galapagos believed so strongly in his work by developing new cancer cell therapies that set their future on the subject. Last winter, the Belgian drug manufacturer announced a plan to turn the rest of the company as an independent business, leaving Legacy Galapagos to focus exclusively on its new approach to manufacture and supply car T cells. Now he is stopping Spin -off plans and, on the other hand, he is exploring strategic alternatives for everything, including cell therapy. The reevaluation of planned business separation follows the “regulatory and market developments” Galapagos said Tuesday. The company is not finishing. But…
For many innovators of Healthtech, the true adoption challenge is not always to prove the clinical value of its product. It is overcoming the structural barriers that get in their way. Then, let’s explore how these obstacles can be navigated and what should Healthtech companies do to success. Regulatory challenges and entry barriers Strict regulations on the health sector, in part those that govern electronic health records (CHR), can suffocate innovation by imposing rigid standards that limit flexibility in design and implementation. On the one hand, its main objective is to promote safety, interoperability and patient safety. In practice, these…
Eli Lilly has already published preliminary data that shows his medicine for obesity, Zepbound surpassed Novo Nordisk’s Wogovy about weight loss measures in a face -to -face clinical trial. The most detailed results, including the key secondary measures of the phase 3 study, provide a greater vision of the comparison, including a key measure that analysts say it helps to give the product Lilly a competitive advantage. In preliminary results, Zepbound treatment for 72 weeks led patients to lose an average of 20.2% of body weight versus 13.7% for those in Wogovy’s arm, fulfilling the main objective of the phase…
The health industry is different from any other sector, particularly when it comes to organizing, adding and sharing data. Most hospitals and health systems feel among a world of fax machines and inherited systems and digital innovation. Megan Zakrewsky’s history are immersed in health innovation, particularly the change in the role to digital medical records, with almost 20 years of his career focused on interoperability. The challenges of the adoption and implementation of health technology are nothing new to it. Her role as an attached professor at the University Thomas Jefferson in Philadelphia while working as a product vice president…
Employers are beginning to wait for more of their medical care providers, whether they are insurance partners, third -party administrators, pharmacy benefits managers, consultants or points solutions. This is especially true because employers have fiduciary responsibility to obtain the best benefits for the best price for their employees. Duration A recent discussion panel at the Midwest Business Group On Health conference in Chicago, a group of employer leaders shared the council they would give to partnership suppliers on how they generate confidence with employers. A panelist said it is important that suppliers be in advance and honest if something goes…
Organizations throughout the health ecosystem have opted for AI. The emotion is justified. Implementing these technologies can save a lot of time and money to do many wonderful things. Unfortunately, however, the implementation of AI can waste a lot of time and money to do many stupid things. One of the worst things that any organization can do to its data architecture are automatic processes to improve the wrong problem. Not only does it waste time and resources, but it increases swelling and strengthening distractions and unnecessary obstacles to function and progress. It is sure to say that the thesis…